2,2-dimethylpropan-1-ol, tribromo derivative; 3-bromo-2,2-bis(bromomethyl)propan-1-ol

CAS36483-57-5
EC253-057-0

List details

Basic info

Status Opinion Adopted
Submitter Norway
Regulatory programme
  • Chemical registered under REACH
ATP number and date ATP18 - (16/02/2022), 23/11/2023
Link to ATP

Classification

Proposed harmonised classification by the dossier submitter
  • Muta. 1B, H340
  • Carc. 1B, H350
Hazard classes open for commenting Germ cell mutagenicity Carcinogenicity Reproductive toxicity Specific target organ toxicity — repeated exposure

Intention timeline

Date of intention 2018-08-20
Expected date of submission 2018-12-31
Submitted for accordance check 2018-12-19
Final submission date 2019-06-14
Start of consultation 2019-07-24
Deadline for commenting 2019-09-24
Date of opinion 2020-06-11
Legal deadline for opinion adoption 2020-12-13

Documents

CLH report
Annexes to the CLH Report
Comments received
Public consultations - received attachments
RAC opinion
Background document

Related substances

By adding any of the following substances to your watchlist, you would be monitoring this regulatory record and all possible new regulatory records related to that substance.

Related regulatory records

Record history

The following timeline shows when we detected changes of this regulatory record (the date might slightly differ from the date of the actual change). Additions between versions are hightlighted in green color, red color shows data removed between versions.

This version
Jan. 18, 2023
  • ATP number and date: ATP18 - (16/02/2022), 23/11/2023
  • Link to ATP / File Title: Official Journal
  • Link to ATP / Full Path: https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=CELEX%3A32022R0692&qid=1667995782196
Jan. 19, 2021
  • Annexes to the CLH Report: https://echa.europa.eu/documents/10162/17172a2c-7a31-cff9-c212-7066b587f253
  • CLH report: https://echa.europa.eu/documents/10162/97640cd4-565c-bddd-dac2-95af503b12eb
  • Public consultations - received attachments: https://echa.europa.eu/documents/10162/78585fed-9339-4cbc-4a4b-4b080b890a74
Dec. 22, 2020
  • Background document: https://echa.europa.eu/documents/10162/bd0b8996-d515-ee8b-e436-56dd18d7194a
  • Comments received: https://echa.europa.eu/documents/10162/c4f4469c-077f-c584-ccec-325eb199d888
Dec. 14, 2020
  • Comments received: https://echa.europa.eu/documents/10162/0e942393-9a0c-9ff8-c908-6f5c76d27657
  • RAC opinion: https://echa.europa.eu/documents/10162/1040019b-b10a-7dc2-3ce7-e7da78c944c4
Dec. 7, 2020
  • Annexes to the CLH Report: https://echa.europa.eu/documents/10162/57feb37a-0b58-b5fa-df9c-14df899e5ca9
  • Background document: https://echa.europa.eu/documents/10162/30a91033-f169-aa0c-22a6-924d2c5bfcbc
  • CLH report: https://echa.europa.eu/documents/10162/4b747f01-3396-771c-2219-98a6c7e14e91
  • Comments received: https://echa.europa.eu/documents/10162/7981e864-e91f-c67f-2dda-d819e5938766https://echa.europa.eu/documents/10162/0e942393-9a0c-9ff8-c908-6f5c76d27657
  • Public consultations - received attachments: https://echa.europa.eu/documents/10162/efabb20d-17e8-7cff-01c6-2edb6955bff8
  • RAC opinion: https://echa.europa.eu/documents/10162/58cd20c5-9926-9899-bdd6-3adbffa92fd5https://echa.europa.eu/documents/10162/1040019b-b10a-7dc2-3ce7-e7da78c944c4
  • RAC opinion: https://echa.europa.eu/documents/10162/aeb7c6a7-9f6a-7bf3-3f33-be6c40aab0fe
Oct. 27, 2020
  • RAC opinion: https://echa.europa.eu/documents/10162/306b4a45-d5a1-f6bb-d2eb-af001bf4b850https://echa.europa.eu/documents/10162/58cd20c5-9926-9899-bdd6-3adbffa92fd5
Sept. 25, 2020
  • Background document: https://echa.europa.eu/documents/10162/30a91033-f169-aa0c-22a6-924d2c5bfcbc
  • Comments received: https://echa.europa.eu/documents/10162/5bd43ec3-e7b5-24d3-b1eb-f0b27898fb18https://echa.europa.eu/documents/10162/7981e864-e91f-c67f-2dda-d819e5938766
  • Date of opinion: 2020-06-122020-06-11
  • RAC opinion: https://echa.europa.eu/documents/10162/306b4a45-d5a1-f6bb-d2eb-af001bf4b850
July 14, 2020
  • Date of opinion: 2020-06-12
  • Status: Opinion DevelopmentOpinion Adopted
May 14, 2020
  • Name: 2,2-dimethylpropan-1-ol, tribromo derivative2,2-dimethylpropan-1-ol, tribromo derivative; 3-bromo-2,2-bis(bromomethyl)propan-1-ol
Oct. 8, 2019
  • Comments received: https://echa.europa.eu/documents/10162/5bd43ec3-e7b5-24d3-b1eb-f0b27898fb18
  • Public consultations - received attachments: https://echa.europa.eu/documents/10162/efabb20d-17e8-7cff-01c6-2edb6955bff8
Oct. 1, 2019
  • Status: Public ConsultationOpinion Development
July 29, 2019
  • Annexes to the CLH Report: https://echa.europa.eu/documents/10162/57feb37a-0b58-b5fa-df9c-14df899e5ca9
  • CLH report: https://echa.europa.eu/documents/10162/4b747f01-3396-771c-2219-98a6c7e14e91
  • Deadline for commenting: 2019-09-24
  • Final submission date: 2019-06-14
  • Hazard classes open for commenting: Germ cell mutagenicity Carcinogenicity Reproductive toxicity Specific target organ toxicity — repeated exposure
  • Legal deadline for opinion adoption: 2020-12-13
  • Status: SubmittedPublic Consultation
  • Start of consultation: 2019-07-24
May 14, 2019
  • Submitter: Norway
May 7, 2019
  • Submitter: Norway
April 4, 2019
  • Regulatory programme: Other substanceChemical registered under REACH
  • Remarks: read-across to EC 221-967-7 (BMP)
Jan. 8, 2019
  • Status: IntentionSubmitted
  • Submitted for accordance check: 2018-12-19
Add the related substance to your watchlist to monitor this regulatory record.